The penetrance of the most common LRRK2 mutation (G2019S) ranges from 28% at 54 years of age to 74% at 79 years of age, suggesting that genetic and environmental modifiers influence lifetime risk for PD in individuals with these mutations. The gene discussed is LRRK2; the disease is Parkinson disease.